Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2000
12/14/2000CA2375602A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations
12/14/2000CA2374256A1 Methods and compounds for the treatment of immunologically-mediated diseases using <i>mycobacterium vaccae</i>
12/14/2000CA2373279A1 Dna methyltransferase inhibitors
12/14/2000CA2373277A1 Immunity generation
12/14/2000CA2339900A1 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/13/2000EP1059086A1 Use of sandal wood oil or constituents of sandal wood oil for the prevention and treatment of warts, skin blemishes and other viral-induced tumors
12/13/2000EP1058723A1 Delivery of proteins into eukaryotic cells with recombinant yersinia
12/13/2000EP1058692A1 Pf4 fragments and pharmaceutical compositions containing same
12/13/2000EP1058690A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/13/2000EP1058687A1 Nucleosides
12/13/2000EP1058686A1 2'-fluoronucleosides
12/13/2000EP1058683A1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
12/13/2000EP1058559A1 Combination of a selective nmda nr2b antagonist and a cox-2 inhibitor
12/13/2000EP1058558A1 Live recombined vaccines injected with adjuvant
12/13/2000EP1058557A1 Enhancement of immunity by intranasal inoculation of il-12
12/13/2000EP1058552A1 Steroid derived antibiotics
12/13/2000EP1058548A1 New use
12/13/2000EP1058547A1 Pharmaceutical compositions containing the phospholipase inhibitor sodium 3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate
12/13/2000EP1058544A1 Inhibition of tnf activity
12/13/2000EP0914144B1 Therapeutic uses of bpi protein products for human meningococcemia
12/13/2000EP0906097A4 Anti-viral compounds
12/13/2000EP0900371A4 Systems and methods for quantifying photoreactions in light activated materials
12/13/2000EP0725641B1 NOVEL INHIBITORS OF URIDINE PHOSPHORYLASE (UrdPase) AND DIHYDROURACIL DEHYDROGENASE (DHUDase)
12/13/2000EP0601062B2 Sirs vaccine and diagnosis method
12/13/2000CN1276833A Vaccine
12/13/2000CN1276797A Low-toxicity human interferon-alpha analog
12/13/2000CN1276794A Triplex forming oligonucleotides and their use in anti-HBV
12/13/2000CN1276730A Use of IFN-alpha and amantadine for treatment of chronic hepatitis C
12/13/2000CN1276728A Therapy for staphylococcus aureus
12/13/2000CN1276726A Method for treating hypercoagulable states or acquired protein C deficiency
12/13/2000CN1276208A Formaldehyde injection for treating infective diseases of animal
12/13/2000CN1059445C Erythromycin derivs, method for preparing same and use thereof as drugs
12/13/2000CN1059438C Stable crystallized cis-isomer of methoxyimino-acetylchloride hydrochloride and process for preparing same
12/13/2000CN1059347C Process for preparing vaccine for hemorrhagic fever with renal syndrome
12/12/2000US6160112 Inhibitors of beta-lactamase
12/12/2000US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds
12/12/2000US6160024 Photoactivated antiviral and antitumor compositions
12/12/2000US6160023 Treatment of an aquatic organism suffering from a disease selected from the group consisting of fungal infections, flagellate protozoan infections, ciliate protozoan infections, bacterial gill disease, and myxobacterial infections
12/12/2000US6159977 Therapeutic anti-fungal nail preparation
12/12/2000US6159973 Aromatic amides, their preparation process, the compositions containing them and their use as pesticides
12/12/2000US6159961 Cephem compounds
12/12/2000US6159949 Polynucleotides, codes and amino acid sequences
12/12/2000US6159937 Immunomodulators
12/12/2000US6159729 For recombinant production and vaccines
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/12/2000US6159706 Application of enzyme prodrugs as anti-infective agents
12/12/2000US6159684 Drug screening of viricides against human immunodeficiency virus; contacting tat, pol ii and hiv promoter sequences linked to gene with compound which blocks tat binding to cyclin-dependent kinase-7, then detecting gene expression
12/12/2000US6159500 Pharmaceutical preparations of glutathione and methods of administration thereof
12/12/2000US6159485 Cosmetics; skin disorders
12/12/2000US6159478 Genetic engineering
12/12/2000US6159477 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus
12/12/2000US6159472 Intradermal Avian immunization with inactivated vaccines
12/12/2000US6159465 Epithelial adhesive lactobacilli
12/12/2000US6159463 Lymphocyte chemoattractant factor
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000CA2131186C Isosteric antiherpes peptide derivatives
12/12/2000CA2063417C Antiviral composition
12/12/2000CA2036413C Hiv protease inhibitors
12/12/2000CA2036397C Hiv protease inhibitors containing derived amino acid units
12/09/2000CA2308691A1 Live attenuated bacteria for use in a vaccine
12/07/2000WO2000073511A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
12/07/2000WO2000073507A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000WO2000073502A2 Essential genes and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
12/07/2000WO2000073476A1 Vector for integration of heterologous sequences into poxviral genomes
12/07/2000WO2000073465A1 Peptides capable of inducing hiv-specific ctl and preventives/remedies for aids containing the peptides
12/07/2000WO2000073456A1 A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073433A1 Screening method for peptides
12/07/2000WO2000073336A1 Fimbrial proteins
12/07/2000WO2000073335A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000WO2000073327A1 Chemokine receptor ccr3 antagonists
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073321A1 Human tumor necrosis factor receptor tr10
12/07/2000WO2000073317A1 3-modified leucomycin derivatives
12/07/2000WO2000073301A1 Bicyclic oxazolidinones as antibacterial agent
12/07/2000WO2000073295A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
12/07/2000WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
12/07/2000WO2000073284A2 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
12/07/2000WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
12/07/2000WO2000073266A1 Novel antioxidants, preparation methods and uses
12/07/2000WO2000073263A1 Cytofectin dimers and methods of use thereof
12/07/2000WO2000073253A1 NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-α MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS
12/07/2000WO2000072878A1 Vaccine against isa virus
12/07/2000WO2000072875A1 A method of prophylaxis and treatment and agents useful for same
12/07/2000WO2000072865A2 Antifungal combination use
12/07/2000WO2000072864A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000WO2000072851A1 Method of sterilizing
12/07/2000WO2000072846A1 Antibacterial compounds
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072840A1 Il-8 receptor antagonists
12/07/2000WO2000072838A1 New use of compounds as antibacterial agents
12/07/2000WO2000072823A1 Preparations for the application of anti-inflammatory agents
12/07/2000WO2000072822A1 Preparations for the application of anti-infective and/or anti-inflammatory agents
12/07/2000WO2000072820A2 Injectable anesthetic formulation
12/07/2000WO2000072818A1 Topical compositions providing improved treatment of skin or scalp fungal infections
12/07/2000WO2000072815A1 Indole derivatives
12/07/2000WO2000072801A2 Alpha v integrin receptor antagonists
12/07/2000WO2000044741A3 Process to prepare cyclic-sulfur fluorine containing oxazolidinones
12/07/2000WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens
1 ... 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 ... 1798